Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H

Alcohol

Volumn 43, Issue 5, 2009, Pages 359-365

  Logrip, Marian L ^a,b   Janak, Patricia H ^a,b,c   Ron, Dorit ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CPP; Dynorphin; Ethanol; Kappa opioid receptor; Reward

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALCOHOL; BRAIN DERIVED NEUROTROPHIC FACTOR; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; PREPRODYNORPHIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; AVERSION; BRAIN NERVE CELL; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; HYPOTHESIS; MOUSE; NONHUMAN; PLACE PREFERENCE; PROTEIN EXPRESSION; RECEPTOR BLOCKING; REWARD; SOCIAL PROBLEM;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CONDITIONING, CLASSICAL; ETHANOL; MICE; MICE, INBRED DBA; MOTOR ACTIVITY; RECEPTORS, OPIOID, KAPPA; REWARD;

EID: 68149169925     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2009.05.001     Document Type: Article

References (35)

1. Bals-Kubik R., Herz A., and Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl) 98 (1989) 203-206
2. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (1982) 413-415
3. Cunningham C.L., Gremel C.M., and Groblewski P.A. Drug-induced conditioned place preference and aversion in mice. Nat. Protoc. 1 (2006) 1662-1670
4. Cunningham C.L., and Noble D. Conditioned activation induced by ethanol: role in sensitization and conditioned place preference. Pharmacol. Biochem. Behav. 43 (1992) 307-313
5. Fadda P., Tronci S., Colombo G., and Fratta W. Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol. Clin. Exp. Res. 23 (1999) 1296-1305
6. Funada M., Suzuki T., Narita M., Misawa M., and Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32 (1993) 1315-1323
7. Iwamoto E.T. Place-conditioning properties of mu, kappa, and sigma opioid agonists. Alcohol Drug Res. 6 (1985) 327-339
8. Koob G.F. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27 (2003) 232-243
9. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
10. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., and Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 28 (2008) 407-414
11. Lindholm S., Werme M., Brene S., and Franck J. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav. Brain Res. 120 (2001) 137-146
12. Logrip M.L., Janak P.H., and Ron D. Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J. 22 (2008) 2393-2404
13. Marinelli P.W., Kiianmaa K., and Gianoulakis C. Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats. Life Sci. 66 (2000) 1915-1927
14. Matsuzawa S., Suzuki T., Misawa M., and Nagase H. Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress. Brain Res. 803 (1998) 169-177
15. Matsuzawa S., Suzuki T., Misawa M., and Nagase H. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress. Eur. J. Pharmacol. 368 (1999) 9-16
16. McLaughlin J.P., Land B.B., Li S., Pintar J.E., and Chavkin C. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31 (2006) 787-794
17. McLaughlin J.P., Li S., Valdez J., Chavkin T.A., and Chavkin C. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31 (2006) 1241-1248
18. McLaughlin J.P., Marton-Popovici M., and Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci. 23 (2003) 5674-5683
19. Mitchell J.M., Liang M.T., and Fields H.L. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl) 182 (2005) 384-392
20. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon Jr. W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 (2001) 7397-7403
21. Przewlocka B., Turchan J., Lason W., and Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci. Lett. 238 (1997) 13-16
22. Samson H.H., and Czachowski C.L. Behavioral measures of alcohol self-administration and intake control: rodent models. Int. Rev. Neurobiol. 54 (2003) 107-143
23. Sandin J., Nylander I., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience 85 (1998) 375-382
24. Shippenberg T.S., and Herz A. Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res. Monogr. 75 (1986) 563-566
25. Shippenberg T.S., LeFevour A., and Heidbreder C. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276 (1996) 545-554
26. Shippenberg T.S., LeFevour A., and Thompson A.C. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593. Eur. J. Pharmacol. 345 (1998) 27-34
27. Spanagel R. The influence of opioid antagonists on the discriminative stimulus effects of ethanol. Pharmacol. Biochem. Behav. 54 (1996) 645-649
28. Suzuki T., Shiozaki Y., Masukawa Y., Misawa M., and Nagase H. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn. J. Pharmacol. 58 (1992) 435-442
29. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
30. Walker B.M., and Koob G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33 (2007) 643-652
31. Weiss F., and Porrino L.J. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J. Neurosci. 22 (2002) 3332-3337
32. Winkler A., and Spanagel R. Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains. Neuroreport 9 (1998) 1459-1464
33. Xuei X., Dick D., Flury-Wetherill L., Tian H.J., Agrawal A., Bierut L., et al. Association of the kappa-opioid system with alcohol dependence. Mol. Psychiatry 11 (2006) 1016-1024
34. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., and Kreek M.J. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology (Berl) 172 (2004) 422-429
35. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., and Kreek M.J. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology (Berl) 173 (2004) 146-152